This company listing is no longer active
2VX Stock Overview
The Flowr Corporation cultivates, produces, and sells cannabis in Canada.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
The Flowr Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.015 |
52 Week High | CA$0.061 |
52 Week Low | CA$0.0065 |
Beta | 0.60 |
11 Month Change | 0% |
3 Month Change | 7.41% |
1 Year Change | -64.20% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -95.99% |
Recent News & Updates
Recent updates
Shareholder Returns
2VX | DE Pharmaceuticals | DE Market | |
---|---|---|---|
7D | 0% | -4.1% | -1.0% |
1Y | -64.2% | -11.4% | 16.1% |
Return vs Industry: 2VX underperformed the German Pharmaceuticals industry which returned 4% over the past year.
Return vs Market: 2VX underperformed the German Market which returned -14.5% over the past year.
Price Volatility
2VX volatility | |
---|---|
2VX Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 7.6% |
Market Average Movement | 5.0% |
10% most volatile stocks in DE Market | 10.9% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 2VX has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 2VX's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2016 | n/a | Darren Karasiuk | www.flowr.ca |
The Flowr Corporation cultivates, produces, and sells cannabis in Canada. The company offers dried flowers and pre-rolls. It also has operations in Canada, Portugal, and the European Union.
The Flowr Corporation Fundamentals Summary
2VX fundamental statistics | |
---|---|
Market cap | €7.35m |
Earnings (TTM) | -€65.33m |
Revenue (TTM) | €8.56m |
0.9x
P/S Ratio-0.1x
P/E RatioIs 2VX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2VX income statement (TTM) | |
---|---|
Revenue | CA$12.43m |
Cost of Revenue | CA$19.91m |
Gross Profit | -CA$7.48m |
Other Expenses | CA$87.32m |
Earnings | -CA$94.81m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -0.22 |
Gross Margin | -60.20% |
Net Profit Margin | -762.84% |
Debt/Equity Ratio | 35.7% |
How did 2VX perform over the long term?
See historical performance and comparison